ACTA Otorhinolaryngologica Italica https://www.actaitalica.it/ <div class="alert-for-new-site alert alert-danger"> <h4><strong>New web site for ACTA Otorhinolaryngologica Italica</strong></h4> <p>As of <strong>22/10/2024</strong>, this site was upgraded and migrated to the new platform with an updated version of the software. The old site remained active and accessible solely to allow completion of the peer-review process for articles submitted prior to the above date.</p> <p>To complete the evaluation/approval process for those articles, the Authors and Reviewers involved will need to access the old site <a href="https://old.actaitalica.it/login" target="_blank" rel="noopener">old.actaitalica.it/login</a> using the usual login credentials.</p> <p>For submission and management of new articles, Authors and Reviewers will have to use this new site using the same login credentials already valid for the old site. If you have difficulty logging in to this new site, you can still perform the password recovery procedure by clicking on the “Forgot your password?” link <a href="https://www.actaitalica.it/login/lostPassword" target="_blank" rel="noopener">www.actaitalica.it/login/lostPassword</a> found on the site's login page.</p> </div> Pacini Editore Srl en-US ACTA Otorhinolaryngologica Italica 0392-100X Cochlear implant procedure. Italian Clinical Practice Guidelines of the Italian Society of Otorhinolaryngology (SIOeChCF) and Italian Society of Audiology and Phoniatrics (SIAF). Part 1: cochlear implants in adults https://www.actaitalica.it/article/view/1134 <p><strong>Objective</strong>. Cochlear implant (CI) is a well-established treatment for adults with sensorineural hearing loss and without benefit from hearing aids. The Italian guidelines date back 15 years; given the expansion of indications for CI, including single side deafness and asymmetrical hearing loss, it became necessary to establish updated guidelines. <br><strong>Methods</strong>. Thirteen experts and 2 patient representatives selected the key questions and drew up recommendations. The document was developed following GRADE methodology. The methodological team of the Mario Negri Pharmacological Research Institute performed systematic reviews for each question and supported the overall process. <br><strong>Results</strong>. Five key questions were identified and recommendations formulated, with subgroups and considerations on implementation.<br><strong>Conclusions</strong>. Though the systematic research of scientific literature found a scarcity of randomised trials and an overall poor conduct and reporting quality of primary studies and systematic reviews, strong or conditional recommendations in favour of CI have been formulated for different subgroups of patients. Further studies should enrol a larger number of participants and use consistent instruments to evaluate hearing outcomes, in order to increase the comparability of results and data pooling with meta-analysis.</p> Stefano Berrettini Domenico Cuda Silvia Minozzi Franca Artioli Umberto Barbieri Cristian Borghi Eliana Cristofari Giorgio Conte Davide Cornolti Diego di Lisi Anna Rita Fetoni Simona Fiori Elisabetta Genovese Giorgia Girotto Marinella Majorano Pasquale Marsella Emanuele Marzetti Maria Nicastri Gaetano Paludetti Nicola Quaranta Patrizia Trevisi Diego Zanetti Michela Cinquini Francesca Forli Sara Ghiselli Copyright (c) 2025 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2025-03-14 2025-03-14 45 47 57 10.14639/0392-100X-N3081 Role of body mass index as a predictor of dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps https://www.actaitalica.it/article/view/1132 <p><strong>Objective</strong>. Response to dupilumab for chronic rhinosinusitis with nasal polyps, albeit almost always excellent, is still not predictable. Our study focuses on the role of body mass index (BMI) on the efficacy of dupilumab. <br><strong>Methods</strong>. We present a retrospective multicentre study of 106 patients on dupilumab, stratified in 3 subgroups of BMI. The main therapeutic outcomes investigated were Nasal Polyp Score (NPS), Sino-Nasal-Outcome Test - 22 (SNOT-22), Sniffin’ Sticks Identification test and visuo-analogical scale, and the different timing of response, according to De Corso et al. criteria. <br><strong>Results</strong>. Dupilumab treatment led to a progressive improvement for all outcomes at all time points. Comparing the different metabolic subgroups, a late response in terms of decrease in NPS was observed only in 3 obese patients. A significant decrease was also found in SNOT-22 score at 6 and 12 months, which was less marked in overweight/obese patients. <br><strong>Conclusions</strong>. Our study confirmed the efficacy of dupilumab in each BMI subgroup. However, the efficacy seems to follow different timing with respect to patients’ BMI. Our data suggest that patients with a compromised metabolic state present more severe disease at baseline and a possibly delayed response to dupilumab.</p> Letizia Nitro Eugenio De Corso Marco Borin Alberto Maria Saibene Flavio Arnone Francesco Ferella Giulia Gramellini Alessandro Cantiani Gabriele De Maio Camilla Spanu Alberto Giulio Dragonetti Giovanni Felisati Carlotta Pipolo Copyright (c) 2025 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2025-03-14 2025-03-14 45 28 38 10.14639/0392-100X-N2841 Blood and local nasal eosinophilia in chronic rhinosinusitis with nasal polyps: prevalence and correlation with severity of disease https://www.actaitalica.it/article/view/1133 <p><strong>Objective</strong>. The aim of this study was to evaluate the clinical relevance of absolute eosinophil blood count and eosinophil count by nasal cytology in the context of real-life clinical practice and to determine if they correlate with the severity of symptoms in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). <br><strong>Methods</strong>. We enrolled 425 patients with CRSwNP followed between January 2015 and April 2023 at the A. Gemelli Hospital Foundation-IRCCS, Rome, Italy. We gathered data on blood and local eosinophil count and correlated the results with clinical features. All patients underwent endoscopy, Visual Analogical Scale (VAS) for main symptoms, and SinoNasal Outcome Test 22 (SNOT-22). <br><strong>Results</strong>. We observed significantly higher mean levels of eosinophils in serum and at nasal cytology in patients with CRSwNP and comorbidities (asthma, non-steroidal anti-inflammatory drugs - exacerbated respiratory disease and allergy) compared to those without. Blood eosinophilia was not associated with severity of symptoms, whereas patients with nasal eosinophil count &gt;&nbsp;5 eosinophils per high-power field at nasal cytology had a significantly higher median specific VAS for nasal symptoms and significantly higher SNOT 22 scores. <br><strong>Conclusions</strong>. We demonstrated that blood eosinophil count and nasal cytology may represent useful tools in routine clinical practice to define Type 2 inflammation and that their levels are usually higher in patients with comorbidities. We also showed that blood eosinophilia was not correlated with severity of symptoms, whereas local eosinophil count was associated with high severity of symptoms and high burden on quality of life.</p> Eugenio De Corso Marco Corbò Claudio Montuori Daniela Furno Veronica Seccia Tiziana Di Cesare Carlotta Pipolo Silvia Baroni Rodolfo Mastrapasqua Alberta Rizzuti Giuseppe D’Agostino Leandro Maria D’Auria Maria Clara Pacilli Jacopo Galli Copyright (c) 2025 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2025-03-14 2025-03-14 45 39 46 10.14639/0392-100X-N2877 Prognostic value of changes in pre- and postoperative inflammatory blood markers in HPV-negative head and neck squamous cell carcinomas https://www.actaitalica.it/article/view/1130 <p><strong>Objective</strong>. Neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) are inflammatory markers easily obtained from a routine complete blood count, and their preoperative values have recently been correlated with oncological outcomes in patients with HPV-negative head and neck squamous cell carcinoma (HNSCC). The aim of this study is to evaluate the prognostic value of NLR and LMR before and after treatment in patients with HPV-negative HNSCC undergoing up-front surgical treatment. <br><strong>Methods</strong>. This multicentric retrospective study was performed on a consecutive cohort of patients treated by upfront surgery for HPV-negative HNSCC between April 2004 and June 2018. Only patients whose pre- and postoperative NLR and LMR were available were included. Their association with local, regional and distant failure, progression-free survival (PFS) and overall survival (OS) was calculated. <br><strong>Results</strong>. A total of 493 patients (mean age 68 years) were enrolled. The mean follow-up time was 54 months. Pre-surgical NLR ≥ 3.76 was associated with a high risk of regional failure (HR = 2.21, 95% CI: 1.08-5.55), disease progression (HR = 1.55, 95% CI: 1.07-2.25) and death (HR = 1.40, 95% CI: 0.94-2.10). A post-surgical LMR &lt; 2.92 had a significant impact on disease progression (HR = 1.92, 95% CI: 1.13-3.28) and OS (HR = 2.98, 95% CI: 1.53-5.81). Patients with stable NLR ≥ 3.76 in the pre- and postoperative period had worse OS and PFS.<br><strong>Conclusions</strong>. Our results support that pre- and postoperative NLR and LMR can be useful in identifying patients at risk of local, regional, or distant recurrence who may require closer follow-up or more aggressive treatment.</p> Tommaso Mazzocco Andrea Migliorelli Giancarlo Tirelli Michele Tomasoni Vittorio Rampinelli Cesare Piazza Marco Ferrari Piero Nicolai Vittorio Baggio Valentina Lupato Francesco Uderzo Franco Trabalzini Simone Mauramati Andrea Ciorba Fabiola Giudici Jerry Polesel Daniele Borsetto Paolo Boscolo-Rizzo Copyright (c) 2025 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2025-03-14 2025-03-14 45 10 20 10.14639/0392-100X-N2955 Complete response of laryngeal papillomatosis after HPV vaccination https://www.actaitalica.it/article/view/682 Alberto Paderno Isabelle Matilde Dohin Francesca Gennarini Copyright (c) 2024 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2024-10-18 2024-10-18 45 1 3 10.14639/0392-100X-N2990 Complications in 2000 adult and paediatric cochlear implants: what to expect and when https://www.actaitalica.it/article/view/1135 <p><strong>Objective</strong>. To identify the incidence of intra- and postoperative complications of adult and paediatric cochlear implants (CIs) in a large cohort with long follow-up. <br><strong>Methods</strong>. Retrospective chart analysis of 2000 consecutive cases of CI in a single institution. <br><strong>Results</strong>. 8.9% of paediatric CIs developed a complication after a mean period of 5.5 ± 5.8 years. 12% of adult CIs developed a complication after a mean period of 3.5 ± 5.3 years. Seroma was the most frequent paediatric complication (1.8%), after a mean of 8.9 ± 5.4 years, while vertigo was the most common complaint in adults (2.5%), emerging in the first year. Both complications were generally managed conservatively. Acute otitis media or abscess with extrusion of the receiver/stimulator required surgical revision, with or without CI explantation, in 23.5% and 76.9% of cases, respectively. Cholesteatoma or chronic otitis media were always treated surgically and required CI explantation in 86.7% of cases. All cases complicated by device failure (1.2% and 0.8% of paediatric and adult CIs, respectively) were treated with CI explantation and reimplantation, and emerged after a mean of 5&nbsp;±&nbsp;4 years. <br><strong>Conclusions</strong>. Knowledge and decades long monitoring of the complications related to CIs are fundamental.</p> Vittoria Sykopetrites Eleonora Sica Flavia Di Maro Eliana Cristofari Copyright (c) 2025 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2025-03-14 2025-03-14 45 58 69 10.14639/0392-100X-N2778 Bama pig is a suitable animal for studying laryngopharyngeal reflux disease https://www.actaitalica.it/article/view/1131 <p><strong>Objective</strong>. To assess the suitability of Bama pigs as a model for laryngopharyngeal reflux disease (LPRD) research. <br><strong>Methods</strong>. Sixteen 8-month-old male Bama pigs underwent esophageal manometry to determine the precise anatomical positioning of the upper (UES) and lower esophageal sphincters (LES) relative to the incisor teeth, as well as their respective contraction intensities. The pigs were randomly allocated into three experimental groups (n = 6, 5, 5), with each group subjected to Dx PH-probe monitoring. In Group 1, animals were fasted for 24 hours and water-deprived for 6 hours before undergoing pH monitoring under anaesthesia. Group 2 was anaesthetised two hours post-normal feeding and subsequently monitored. Group 3 also received anaesthesia two hours after eating but were monitored in an awake state. <br><strong>Results</strong>. The mean distance from the UES to the incisor teeth was found to be 19.8&nbsp;±&nbsp;1 cm, while the LES was located at 40 ± 2.5 cm. The resting pressure measurements revealed a mean value of 64&nbsp;±&nbsp;12 mmHg for the UES and 20&nbsp;±&nbsp;4 mmHg for the LES in Bama pigs. Laryngopharyngeal pH values across the three groups were 7 ± 0.6, 7 ± 0.5, and 7.4 ± 1.2, respectively, showing no significant differences or reflux events. Similarly, there was no statistically significant difference in the lower oesophageal pH between Group 1 and Group 2. <br><strong>Conclusions</strong>. The Bama pig emerges as a suitable animal model for studying LPRD, given its comparable physiological parameters. The feasibility of establishing a reflux model in Bama pigs and using it to investigate the underlying mechanisms of LPRD is convincingly supported by these findings.</p> Qingyang Shi Yuguang Wang Lihong Zhang Haiyan An Copyright (c) 2025 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2025-03-14 2025-03-14 45 21 27 10.14639/0392-100X-N2734 Spontaneous neck haemorrhage secondary to parathyroid adenoma: description of a case and systematic review https://www.actaitalica.it/article/view/1129 <p><strong>Introduction</strong>. Parathyroid adenomas can rarely cause spontaneous haemorrhage, which can be life-threatening. Diagnosis is challenging. We present a case and systematic review to define a clearer pattern of symptoms, diagnosis, and treatment. <br><strong>Materials and methods</strong>. We conducted a literature search of PubMed, Google Scholar, and Embase using PRISMA guidelines, identifying 38 relevant case reports on spontaneous neck bleeding or haematoma caused by parathyroid adenomas from 1974 to 2020. Data included epidemiology, clinical features, and treatment. One patient treated at our clinic is described.<br><strong>Results</strong>. Reviewing 38 articles, we found cervical haematomas from spontaneous bleeding of parathyroid adenoma in 45 patients, comprising 33 women and 12 men. Common symptoms were neck pain, dysphagia, and swelling. Surgery was the primary treatment, with 4.4% requiring tracheotomy. Average hospital stay was 12.5 days, which was mostly complication-free. <br><strong>Conclusions</strong>. Parathyroid adenoma haemorrhage in middle-aged women with neck swelling, pain, and swallowing difficulty should be suspected. Diagnosis involves blood tests and contrast CT. Treatment is adenoma removal, typically without major complications.</p> <p>&nbsp;</p> Alberto Vito Marcuzzo Sara Fadda Kevin Cargnelutti Simone Zucchini Lara Bigolin Pierluigi Bonini Giancarlo Tirelli Copyright (c) 2025 Società Italiana di Otorinolaringoiatria e chirurgia cervico facciale http://creativecommons.org/licenses/by-nc-nd/4.0 2025-03-14 2025-03-14 45 1 9 10.14639/0392-100X-N3055